Abiopharma

General Announcement: Business Updates for the First Quarter ended 31 March 2026

General Announcement: MoneyMax successfully raises S$44.3 million from issuance of 53 million new ordinary shares

Events and transactions

Register of shareholders, changes and share capital status – exercise of warrants into the company’s ordinary shares

Change in holdings of interested parties/officers

Change in holdings of interested parties/officers

Register of shareholders, changes and share capital status – allocation of unregistered warrants

Events and transactions

Tender offer - specification

Transaction with a controlling shareholder

Holdings of interested parties/officers as of 31.3.26

General Announcement: Press Release - Serial Achieva secures contract for AI infrastructure solutions

Events and transactions

Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026

Prospectus, shelf prospectus, shelf offering report